Fosun International LTD Alnylam Pharmaceuticals, Inc. Transaction History

Fosun International LTD

  • $106 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023
BUY
$182.66 - $235.53 $498,661 - $642,996
2,730 New
2,730 $546,000
Q3 2019

Nov 12, 2019
SELL
$70.9 - $87.82 $3.85 Million - $4.77 Million
-54,300 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$65.86 - $92.79 $395,160 - $556,740
6,000 Added 12.42%
54,300 $3.86 Million
Q4 2018

Jan 31, 2019
BUY
$62.67 - $88.33 $739,506 - $1.04 Million
11,800 Added 32.33%
48,300 $3.31 Million
Q3 2018

Nov 09, 2018
BUY
$87.52 - $122.67 $3.19 Million - $4.48 Million
36,500 New
36,500 $3.29 Million

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email